logo
Select company
Select metric
$ 67.24MNet Cash Flow - Financing
VS
Market
20
Sector
19
Industry
24
History
22
$ 13.99Close
$ 3.59 - $ 14.97 52-Week Range
Ticker Information

Ticker

AVTX

Company Name

AVALO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

AVALO THERAPEUTICS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AVTX - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 67.24M
3/31/2025$ 67.24M
12/31/2024$ 175.85M
9/30/2024$ 108.14M
6/30/2024$ 118.84M
3/31/2024$ 119.91M
12/31/2023$ 25.04M
9/30/2023$ 25.12M
6/30/2023$ 14.43M
3/31/2023$ -951K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AVALO THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 44.72M.
  • Over the past 5 years, AVALO THERAPEUTICS INC's average CF - Financing has been $ 61.46M.
  • The median CF - Financing for AVALO THERAPEUTICS INC during this period was $ 63.24M
  • AVALO THERAPEUTICS INC reached its highest CF - Financing over the past 5 years at $ 175.85M.
  • The lowest CF - Financing recorded by AVALO THERAPEUTICS INC in the same timeframe $ -14.71M

AVALO THERAPEUTICS INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
COYA : COYA THERAPEUTICS INC $ 9.65MABVC : ABVC BIOPHARMA INC $ 2.79MVTGN : VISTAGEN THERAPEUTICS INC $ 4.61MRPTX : REPARE THERAPEUTICS INC $ 246KINO : INOVIO PHARMACEUTICALS INC $ 30.8MENTX : ENTERA BIO LTD $ 16.52MCOEP : COEPTIS THERAPEUTICS HOLDINGS INC $ 8.43MIBIO : IBIO INC $ 8.93MPULM : PULMATRIX INC $ 0ERNA : ERNEXA THERAPEUTICS INC $ 12.08M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

AVTX - Net Cash Flow - Financing, Last 5 years

$ -14.71M

Minimum

Sep 30, 2022

$ 175.85M

Maximum

Dec 31, 2024

$ 61.46M

Average

$ 63.24M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.25M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.84M
median$ 305K
std$ 119.25M